Skip to search.
 TSX Up 0.47% TSX Ventures Up 1.46%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
1.66 Down 0.05(2.92%) 4:00PM EDT
|After Hours : 1.66 0.00 (0.00%) 4:00PM EDT
Prev Close:1.71
Open:1.71
Bid:1.59 x 5000
Ask:1.75 x 2600
1y Target Est:5.00
Beta:2.59464
Earnings Date:May 9 - May 13 (Est.)
Day's Range:1.65 - 1.75
52wk Range:1.50 - 4.42
Volume:622,074
Avg Vol (3m):989,303
Market Cap:201.32M
P/E (ttm):N/A
EPS (ttm):-0.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IDRADown 2.92%201.32M
PFEDown 0.61%202.54B
DVAXDown 6.39%631.49M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3,317.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.45
Quarterly EPS Est (Mar-16) :-0.11
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for oncology and rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback